To Evaluate the Efficacy and Safety of N-acetyl Cysteine Administration in Patients With Diabetic Retinopathy

NCT07634991 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy (DR)

Interventions

DRUG: N Acetyl cysteine, 1200mg (high dose)

Sponsor

Ain Shams University

Collaborators

[object Object]